ClinicalTrials.gov
ClinicalTrials.gov Menu

Measurement of Renal Function With Iohexol in Subjects Ingesting Carnitine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01392313
Recruitment Status : Withdrawn
First Posted : July 12, 2011
Last Update Posted : July 12, 2011
Sponsor:
Information provided by:
Montefiore Medical Center

Brief Summary:
The investigators will measure renal function in subjects ingesting carnitine to determine if the product alters renal function.

Condition or disease Intervention/treatment Phase
Carnitine Ingestion Dietary Supplement: Carnitine Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 5 participants
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Measurement of Glomerular Filtration Rate (GFR) Using Iohexol in Healthy Subjects Taking Creatinine Supplements
Study Start Date : May 2010
Estimated Primary Completion Date : June 2010
Estimated Study Completion Date : June 2010

Resource links provided by the National Library of Medicine



Intervention Details:
  • Dietary Supplement: Carnitine
    Carnitine Ingestion


Primary Outcome Measures :
  1. Iohexol clearance [ Time Frame: 1 month ]
    Iohexol clearance will be measured



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • carnitine ingestion

Exclusion Criteria:

  • renal disease

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01392313


Locations
United States, New York
Montefiore Medical Center
Bronx, New York, United States, 10467
Sponsors and Collaborators
Montefiore Medical Center

Responsible Party: Joel Neugarten MD, Montefiore Medical Center
ClinicalTrials.gov Identifier: NCT01392313     History of Changes
Other Study ID Numbers: 10-03-068
First Posted: July 12, 2011    Key Record Dates
Last Update Posted: July 12, 2011
Last Verified: July 2011

Keywords provided by Montefiore Medical Center:
carnitine, kidney